Investors always look for companies with a high level of profitability regardless of the present market condition.
MediWound (MDWD) delivered earnings and revenue surprises of 35.71% and 4.42%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Recap: MediWound Q1 Earnings

11:13am, Wednesday, 20'th May 2020
Shares of MediWound (NASDAQ:MDWD) moved higher by 6% in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share rose 40.00% over the past year to ($0.09), which b
YAVNE, Israel, May 20, 2020 -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs.

MediWound Ltd. to Host Earnings Call

10:30am, Wednesday, 20'th May 2020
NEW YORK, NY / ACCESSWIRE / May 20, 2020 / MediWound Ltd. (NASDAQ:MDWD) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 20, 2020 at 8:30 AM Easter
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ADC Therapeutics SA (NYSE:...
Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available online ...
YAVNE, Israel, May 13, 2020 -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn.
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE